Universal vaccination against hepatitis B - cost versus ethics

Tom Fletcher; Nicholas Beeching

Universal vaccination against hepatitis B - cost versus ethics

Clinical Sciences and International Public Health

Research output: Contribution to journal › Article › peer-review

Abstract

Hepatitis B virus (HBV) is a global public health problem, even though vaccines have been available for almost 30 years. Worldwide, it is estimated that over 450 million are chronically infected, and that 500,000 to 1.2 million people die from HBV-realated illness each year

Original language	English
Pages (from-to)	06-Jul
Journal	Viral Hepatitis in Practice
Publication status	Published - 1 Jul 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://www.haywardpublishing.co.uk/_year_search_review.aspx?JID=10&Year=2011

Cite this

@article{06d5e577a96d4759b11d487933b853a1,

title = "Universal vaccination against hepatitis B - cost versus ethics",

abstract = "Hepatitis B virus (HBV) is a global public health problem, even though vaccines have been available for almost 30 years. Worldwide, it is estimated that over 450 million are chronically infected, and that 500,000 to 1.2 million people die from HBV-realated illness each year",

author = "Tom Fletcher and Nicholas Beeching",

year = "2011",

month = jul,

day = "1",

language = "English",

pages = "06--Jul",

journal = "Viral Hepatitis in Practice",

issn = "2041-1162",

publisher = "not in scopus",

}

TY - JOUR

T1 - Universal vaccination against hepatitis B - cost versus ethics

AU - Fletcher, Tom

AU - Beeching, Nicholas

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Hepatitis B virus (HBV) is a global public health problem, even though vaccines have been available for almost 30 years. Worldwide, it is estimated that over 450 million are chronically infected, and that 500,000 to 1.2 million people die from HBV-realated illness each year

AB - Hepatitis B virus (HBV) is a global public health problem, even though vaccines have been available for almost 30 years. Worldwide, it is estimated that over 450 million are chronically infected, and that 500,000 to 1.2 million people die from HBV-realated illness each year

M3 - Article

SN - 2041-1162

SP - 06-Jul

JO - Viral Hepatitis in Practice

JF - Viral Hepatitis in Practice

ER -

Universal vaccination against hepatitis B - cost versus ethics

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this